Top 10 Pharmaceuticals markets in the UAEThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in the UAE, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $185 Mn | $1.8 Bn | 25.9% | 0 |
| 2 | Cell Based Immunotherapy | $83 Mn | $713 Mn | 24% | 25 |
| 3 | Cannabidiol (CBD) | $110 Mn | $567 Mn | 17.8% | 0 |
| 4 | Cannabis | $170 Mn | $657 Mn | 14.5% | 0 |
| 5 | Atopic Dermatitis Drugs | $56 Mn | $194 Mn | 13.2% | 5 |
| 6 | Oncology/Cancer Drugs | $885 Mn | $2.2 Bn | 9.4% | 16 |
| 7 | Anti-Aging | $441 Mn | $1.1 Bn | 9.1% | 0 |
| 8 | Diabetes Management | $390 Mn | $850 Mn | 8.1% | 13 |
| 9 | Alzheimer Drugs | $25 Mn | $53 Mn | 7.8% | 3 |
| 10 | Contraceptives Drugs | $126 Mn | $267 Mn | 7.8% | 0 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $885 Mn | $2.2 Bn | 9.4% | 16 |
| 2 | Anti-Aging | $441 Mn | $1.1 Bn | 9.1% | 0 |
| 3 | Diabetes Management | $390 Mn | $850 Mn | 8.1% | 13 |
| 4 | Gastrointestinal Drugs | $270 Mn | $466 Mn | 5.6% | 9 |
| 5 | Asthma & COPD Drugs | $248 Mn | $403 Mn | 5% | 4 |
| 6 | Biosimilars | $185 Mn | $1.8 Bn | 25.9% | 0 |
| 7 | Cannabis | $170 Mn | $657 Mn | 14.5% | 0 |
| 8 | HIV Drugs | $150 Mn | $290 Mn | 6.8% | 0 |
| 9 | Contraceptives Drugs | $126 Mn | $267 Mn | 7.8% | 0 |
| 10 | Cancer Supportive Care Drugs | $124 Mn | $216 Mn | 5.7% | 1 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 25.9% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24%).
Oncology/Cancer Drugs is the largest, worth about $885 Mn in 2023 and $2.2 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
Saudi Arabia